EyeSense AG is a spin-off company from CIBA Vision (the Novartis eye care company).
Business goal is to develop and commercialize an ophthalmic self-diagnostic device for blood glucose monitoring. The company is exploiting the unique environment of the eye in conjunction with a specific and accurate sensor technology for pioneering a convenient, blood- and pain-free new blood glucose monitoring device. This breakthrough concept allows the diabetic as often as he wants to gain information on his blood glucose level over the day only by means of a small handheld photometer.

Web: eyesense.com/en/investoren.htm